clinician-scientist

Bern medical oncology chief whose lab targets leukaemia stem cells and CD70 signalling.

Hematologist who directs Kyoto University Hospital, one of Japan's leading academic medical centres.

Oncology pharmacist-scientist at UC Irvine and President of MASCC, the multinational society for supportive care in cancer, known for research on cancer-related cognitive impairment.

Lille pulmonologist and thoracic oncologist who presides over the IFCT, France's academic lung cancer trials group.

Thoracic oncologist who heads the Oncology Division at Geneva University Hospitals.

Physician who directs the Naef K. Basile Cancer Institute, the multidisciplinary cancer centre of the American University of Beirut Medical Center in Lebanon.

Medical oncologist from Gipuzkoa who became President of GEICAM, Spain's academic breast cancer research group, in 2025 on the retirement of its founder Miguel Martín.

Radiation oncologist specialising in head and neck cancer who oversees clinical affairs at Poland's National Research Institute of Oncology.

Oslo gynaecological oncology surgeon at the Norwegian Radium Hospital and President-Elect of ESGO.

Pathologist and Scientific Director of the Candiolo Cancer Institute (INOC), Piedmont's oncology IRCCS and an OECI-certified Comprehensive Cancer Centre.

Chief physician who directs Tays Cancer Centre in Tampere and the FICAN Mid regional cancer centre for central Finland.

Leading nasopharyngeal carcinoma researcher who directs the Hong Kong Cancer Institute at CUHK.

Ferrara haematologist and CLL expert who chairs GIMEMA's Scientific Committee.

Gynaecological medical oncologist directing the Cancer Center Clínica Universidad de Navarra; led the PRIMA trial of niraparib maintenance in ovarian cancer.

Immunologist and Scientific Director of the Istituto Oncologico Veneto, leading its translational cancer research.

Veteran Italian medical oncologist who leads oncology and haematology at Humanitas and has co-authored major trials in lymphoma, liver cancer and novel targeted drugs.

Physician who directs Ramathibodi Hospital, the university hospital of the Faculty of Medicine Ramathibodi Hospital at Mahidol University in Bangkok.

Cancer biologist who directs the Cancer Research UK Convergence Science Centre, the joint Institute of Cancer Research and Imperial College London programme bringing engineering and physical sciences into cancer research.

Milan radiation oncologist leading ESTRO, Europe's radiotherapy and oncology society.

Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma.

Blood cell molecular biologist who has led Sydney's Garvan Institute of Medical Research since 2023, sharpening its focus on genomics, immunology and cancer.

Physician who serves as Director of Christian Medical College, Vellore, the not-for-profit teaching hospital and medical school in Tamil Nadu, India.

Oncologist who leads the Barbara Ann Karmanos Cancer Institute in Detroit as President and CEO and chairs the Department of Oncology at Wayne State University.

Epigenetics researcher who became CEO of Huntsman Cancer Institute at the University of Utah in September 2025.

Geneticist known for work on the genetic drivers of childhood brain cancer who became Director and CEO of QIMR Berghofer, a leading Australian medical research institute, in 2026.

Urologist who has served as President of Hospital de Clínicas de Porto Alegre, a leading Brazilian university hospital, since 2024.

Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted.

Hepatologist at Clínica Universidad de Navarra and a leading international investigator in liver cancer systemic therapy and radioembolisation.

Principal investigator of HARMONi-2, the trial where ivonescimab beat pembrolizumab head-to-head, and of the first EGFR-TKI phase 3 in Chinese patients.

Cancer epidemiologist who co-leads KWF, the Dutch Cancer Society, the Netherlands' largest charitable funder of cancer research.

Rheumatologist who is Dean of Medicine at the University of Hong Kong, the academic partner of Queen Mary Hospital, and formerly chief of the hospital's Department of Medicine.

Edinburgh medical oncologist and ovarian cancer researcher who is Clinical Director of the CRUK Scotland Centre.

Medical oncologist who leads Singapore's National University Cancer Institute (NCIS), the country's public cancer centre for adults and children.

Plastic and reconstructive surgeon who leads Linkou Chang Gung Memorial Hospital, the flagship medical centre of Taiwan's Chang Gung hospital system.

Blood cancer specialist who leads the Juravinski Cancer Centre, one of Ontario's largest integrated cancer programmes, as Vice President of Oncology.

Haematologist-oncologist who is Managing Director of the University Cancer Center Frankfurt.

Physician who directs the University of Wisconsin Carbone Cancer Center, the NCI-designated comprehensive cancer centre in Madison.

Gynaecological oncologist at the Medical University of Vienna and ABCSG Vice-President, known for work on breast cancer and hereditary cancer risk.

Kiel professor of medicine who serves as President of the German Lymphoma Alliance, the umbrella body for German lymphoma study groups, alongside co-president Georg Lenz.

Australian medical oncologist whose landmark NEJM analysis showed KRAS mutation predicts lack of benefit from cetuximab in colorectal cancer.

Paediatric haematologist-oncologist and National Academy of Medicine member who is Interim Director of the IU Simon Comprehensive Cancer Center in Indianapolis.

Professor of urology and of cellular and molecular medicine who directs the University of Arizona Cancer Center, the NCI-designated cancer centre in Tucson.

Radiation oncologist who chairs the directorate of the University Cancer Center Inselspital in Bern.

Cancer biologist who has been President and CEO of The Wistar Institute in Philadelphia since 2015 and directs its NCI-designated Ellen and Ronald Caplan Cancer Center.

Nobel laureate biochemist who founded and directs the Institute for Protein Design, which builds new proteins for medicine including cancer therapeutics.

Medical oncologist who is Clinical Director for Cancer Services at St Vincent's University Hospital and its UCD Cancer Centre in Dublin, Ireland's largest cancer care provider.

Gustave Roussy thoracic oncologist on the IFCT board, widely published on BRAF- and EGFR-targeted therapy in lung cancer.

Medical oncologist who leads cancer services at Cork University Hospital as Clinical Director, with a focus on gynaecological and thoracic cancers and early-phase trials.

Medical oncologist who leads the oncology clinical programme across Intermountain Health's cancer centres in Utah and neighbouring states.

Pancreatic cancer surgeon-scientist who directs UC San Diego Moores Cancer Center, an NCI-designated comprehensive cancer center.

Physician who directs Ho Chi Minh City Oncology Hospital, the main public cancer hospital serving southern Vietnam.

Melanoma expert who directs the West German Cancer Center at University Hospital Essen.

Executive Director of the Ocean Road Cancer Institute, Tanzania's national cancer hospital in Dar es Salaam.

Breast cancer biologist and Chief Scientific Officer of the Breast Cancer Research Foundation, directing its global research grant portfolio.

Dermatologist and geneticist who has been chief executive of Tel Aviv Sourasky Medical Center, a major Israeli academic hospital, since 2024.

Internal medicine oncologist who directs the Comprehensive Cancer Center Freiburg and heads its clinical trials unit.

Professor who runs the Centre Antoine Lacassagne, the regional cancer centre in Nice, as its Directeur Général.

Madrid breast oncologist and Vice President of the SOLTI breast cancer research group.

Urological surgeon who is Chief Executive Officer of the Aga Khan University Hospital and Health System in Pakistan, based at the Karachi teaching hospital.

Tumour biologist known for linking inflammation to cancer, directing the Georg-Speyer-Haus within UCT Frankfurt.